Instructional BiologyWhy the carrier (exosome) matters as much as the cargo
A biologically active peptide that never reaches its intended target, intact, is not a therapeutic — it's an interesting molecule. The gap between "active in a test tube" and "active where it needs to be, in a living system" is where a large share of promising biology quietly fails. Naked peptides degrade in circulation, get cleared before reaching their target tissue, or trigger immune responses that block repeated use. Solving the carrier (exosome) problem is not a secondary engineering detail; it's frequently the deciding factor in whether a biologically sound idea becomes a workable one.
Our carrier (exosome) manufacturing system is built around engineered delivery vesicles — structures modeled on the body's own extracellular vesicle transport mechanisms, engineered to protect a payload in circulation and improve the odds it reaches its intended destination intact.
Why "configured per individual" is the actual innovation
A generic delivery vesicle, built once and used identically for every patient, is still a population-average solution wearing a more sophisticated wrapper. What we think matters more is configuring the carrier (exosome) itself based on the same individual signaling context our reasoning system is already mapping — informed by the same evidence graph that identifies which signaling relationships are relevant for a given case, rather than a fixed specification applied uniformly.
This is the connective tissue between our reasoning system and our carrier (exosome) manufacturing system: one maps the biology, the other manufactures the delivery mechanism informed by that map. Neither is fully useful without the other — a perfectly mapped hypothesis with no way to deliver it stays theoretical, and a sophisticated carrier (exosome) with no individualized targeting logic behind it is just an expensive generic vehicle.
Where this connects to bespoke therapeutics
This system is the manufacturing expression of the bespoke-therapeutics thesis we've written about separately: genuine individualization requires both a way to reason about individual biological context and a way to physically act on that reasoning. The carrier (exosome) manufacturing system is the second half of that pair — the part that turns an individualized hypothesis into something that can actually be manufactured and delivered.